Medinol v. Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
Stent maker Medinol's ongoing suit against distributor Boston Scientific Chairman Pete Nicholas and CFO Larry Best will be allowed to proceed alongside other suits between the parties related to alleged supply agreement violations under a New York federal court ruling denying the execs' motion for dismissal. The court's action, which also dismissed personal claims against other Boston Scientific employees, comes three months after dismissal of similar claims against the individual managers of Medinol. Boston Scientific maintains the actions are preliminary and not expected to adversely impact the overall litigation. The New York proceedings are separate from ongoing shareholder rights litigation brought against Medinol in Israel by minority stakeholder Boston Scientific...